Anlon Healthcare Ltd

Stage 2 · Advancing · week 16

As of 16 Oct 2026, Anlon Healthcare is in Stage 2 — advancing, the uptrend phase, in week 16 (since 25 Jun 2026). It closed at ₹26.85, 26.2% below its 52-week high and above its 200-day average, which is rising. In Health Care, 40.0% of stocks are in Stage 2.

Anlon Healthcare Limited manufactures and sells advance pharmaceutical intermediates in India and internationally. More about the company

₹26.9
-2.68% today
₹1,427 Cr · Small cap
Market Neutral — FadingHealth Care 40.0% in Stage 2-7.4 pts / 20dPharmaceuticals 49.6%-2.5 pts

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #57 of 59 in Pharmaceuticals · #68 of 70 in Health Care

Is AHCL early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
-26.2%
₹10.8 lo₹36.4 hi
26.2% below 52W high — far from high
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 16
1w13w26w
Week 16 — proven structure, sweet spot
How long this stock has been in Stage 2. The sweet spot is mid-run — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
72.4%
200 DMA: ₹15.6 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.45x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↑
MA20 trending up · +22.7% vs MA50 +37.6%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
+34.0%
3M
+82.3%
6M
+90.1%
YTD
+93.9%
1Y
+105.8%
Sector
Health Care
↓ Peaking
Stage 2%
40.0%
20d Δ
-7.4pp
1M return
-3.8%
3M return
-1.0%
Sector Stage-2 % · last 20 days
This stock ranks #8 of 66 Stage 2 stocks in Health Care by RS. Leading the sector.
Industry
Pharmaceuticals
↓ Peaking
Stage 2%
49.6%
20d Δ
-2.5pp
1M return
-2.3%
3M return
-0.6%
Industry Stage-2 % · last 20 days
Ranks #8 of 56 Stage 2 stocks in this industry. Top tier.
Stage Cycle Timeline2025-12-26 → 2026-10-16
S? 26w
S2 16w
2025-12-262026-10-16
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 26w → S2 16w current
Total tracked: 42 weeks across 2 stage runs.
Scan Membership
Prop Scan
Latest: 2026-10-13
Breakout Watch
Latest: 2026-06-25
4 appearances in last 60 days. First seen: 2026-06-25.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-16S2
Wk 16 · Vol 0.45x
2026-10-15S2
Wk 16 · Vol 0.18x
2026-10-14S2
Wk 16 · Vol 0.48x
2026-10-13S2
Wk 16 · Vol 0.87x
2026-10-12S2
Wk 16 · Vol 0.42x
2026-10-09S2
Wk 15 · Vol 0.82x
2026-10-08S2
Wk 15 · Vol 0.82x
2026-10-07S2
Wk 15 · Vol 0.09x
2026-10-06S2
Wk 15 · Vol 0.49x
2026-10-05S2
Wk 15 · Vol 0.04x
2026-10-01S2
Wk 14 · Vol 0.06x
2026-09-30S2
Wk 14 · Vol 0.77x
Sector Peers — Stage 2All →
BAFNAPH
wk 19 · 0.0% from hi
8.6
KILITCH
wk 3 · -11.6% from hi
8.4
LAURUSLABS
wk 26 · -0.4% from hi
7.8
KOPRAN
wk 20 · -6.8% from hi
7.4
ZIMLAB
wk 23 · -5.2% from hi
6.9
Moving averages & range
50 DMA
₹21.4
200 DMA
₹15.6
52W High
₹36.4
52W Low
₹10.8
5D Low
₹26.9
Resistance levels (recent highs)
20d High
₹36.4
60d High
₹36.4
120d High
₹36.4
250d High
₹36.4
Next resistance
+35.5%
to 20d High
Ask the Market AI about AHCLAsk →
P/E (TTM)
21.9
Forward —
About this companyHealth Care· Pharmaceuticals

Anlon Healthcare Limited manufactures and sells advance pharmaceutical intermediates in India and internationally. The company offers active pharmaceutical ingredients (API); nutraceutical API products; personal care ingredients; and veterinary API products. Its products are used in anti-inflammatory (NSAID), analgesic, antipyretic, antihistamine, antidepressant, antipsychotic, anticoagulant, antihypertensive, nutrition, anti-arrhythmic, anti-hyper parathyroid, antiplatelet, ant diabetic, gastroesophageal reflux disease (GERD), and anti-rheumatic therapeutics areas. The company was incorporated in 2013 and is based in Rajkot, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.